A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

OBJECTIVE: Arhalofenate is a novel antiinflammatory uricosuric agent. The objective of this study was to evaluate its antiflare activity in patients with gout. METHODS: This was a 12‐week, randomized, double‐blind, controlled phase IIb study. Eligible patients had had ≥3 flares of gout during the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Poiley, Jeffrey, Steinberg, Alexandra S., Choi, Yun‐Jung, Davis, Charles S., Martin, Robert L., McWherter, Charles A., Boudes, Pol F., Bays, H., Bolshoun, D., Bolster, E., Cheung, D., Cone, C., DeGarmo, R., Earl, J., El Asmar, I., Felber, D., Fitz‐Patrick, D., Gaffo, A., Gottschlich, G., Greenwald, J., Griffin, C., Guice, M., Harper, W., Hill, J., Huffman, C., Huling, R., Johnson, F., Kafka, S., Keane, J., Kirby, W., Kirstein, J., Kolettis, E., Lefebvre, G., Mabaquiao, A., Maynard, K., McIlwain, H., McNeill, R., Mehta, D., Montgomery, R., Morgan, C., Poiley, J., Powell, S., Radbill, K., Reschak, M., Surowitz, R., Tarro, J., Turner, M., Velazquez, F., Watkins, L., White, J., Williams, H., Wilson, J., Zaidi, F., Henein, S., Toma, A., Burtchuladze, T., Kartvelishvili, E., Kilasonia, L., Lagvilava, L., Shalamberidze, L., Tsiskarishvili, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Gout
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129473/
https://www.ncbi.nlm.nih.gov/pubmed/26989892
http://dx.doi.org/10.1002/art.39684

Ejemplares similares

Ejemplares similares